Browse studies, page 1271
Page 1271 of 1,286, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Impact of Guideline Adherence on Outcomes in Patients Hospitalized with Community-Acquired Pneumonia (CAP) in Hungary: A Retrospective Observational Study Antibiotics (Basel, Switzerland), 2022
- Overview of Side-Effects of Antibacterial Fluoroquinolones: New Drugs versus Old Drugs, a Step Forward in the Safety Profile? Pharmaceutics, 2023
- Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence Frontiers in pharmacology, 2022
- Third-Generation Tetracyclines: Current Knowledge and Therapeutic Potential Biomolecules, 2024
- Nosocomial pneumonia: Current etiology and impact on antimicrobial therapy Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2023
- Optimizing Treatment for Carbapenem-Resistant Acinetobacter baumannii Complex Infections: A Review of Current Evidence Infection & chemotherapy, 2024
- Overview of changes in the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing: M100 32nd and 33rd editions Journal of clinical microbiology, 2025
- Antimicrobial-laden PerOssal beads display in vitro inhibition and killing of extensively drug-resistant Gram-negative bacteria associated with conflict wounds in Ukraine Bone & joint research, 2026
- Challenges and opportunities in the management of severe pneumonia. Key concepts from the Seventh Annual Meeting of Spanish Experts 2025 Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2026
- BK Polyomavirus Infection in Kidney Transplantation: A Comprehensive Review of Current Challenges and Future Directions International journal of molecular sciences, 2024
- Comparative analysis of treatment outcomes and risk factors associated with different combination antimicrobial regimens in patients with multidrug-resistant Acinetobacter baumannii pneumonia Frontiers in cellular and infection microbiology, 2026
- Cardiovascular adverse effects of common non-oncologic medications: from mechanisms to clinical management European heart journal. Cardiovascular pharmacotherapy, 2026
- Metallo-β-lactamase-producing Pseudomonas aeruginosa: epidemiology, diagnostic challenges and therapeutic strategies in the era of MDR/XDR resistance Frontiers in microbiology, 2026
- Comparative In vitro antibacterial activity of nemonoxacin and other fluoroquinolones in correlation with resistant mechanisms in contemporary methicillin-resistant Staphylococcus aureus blood isolates in Taiwan Annals of clinical microbiology and antimicrobials, 2025
- Eravacycline: From broad-spectrum coverage to novel clinical applications Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2026
- Role of Cefiderocol in the Treatment of Carbapenem-Resistant Nonfermenting Gram-Negative Bacilli (Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia) Infections: An Expert Statement Infectious diseases and therapy, 2026
- Serious Adverse Drug Reactions Associated with Off-Label and Unlicensed Drug Use in Children: A 14-Year Analysis of VigiBase Reports from Serbia Children (Basel, Switzerland), 2026
- Therapeutic Drug Monitoring: The Need for Practical Guidance Clinical Infectious Diseases, 2018
- The use of in vitro pharmacodynamic models of infection to optimize fluoroquinolone dosing regimens Journal of Antimicrobial Chemotherapy, 2000
- In Vitro Activity of Delafloxacin and Microbiological Response Against Fluoroquinolone Susceptible and Non-Susceptible S. aureus Isolates from Two Phase 3 Studies of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) 2016
- Ciprofloxacin dosage and emergence of resistance in human commensal bacteria Journal of Infectious Diseases, 2009
- Guide to selection of fluoroquinolones in patients with lower respiratory tract infections Drugs, 2012
- Doripenem monohydrate, a broad-spectrum carbapenem antibiotic Clinical Therapeutics, 2009
- Fluoroquinolone Antibiotic Prophylaxis to Prevent Post-Traumatic Bacterial Infectious Endophthalmitis: Using Monte Carlo Simulation to Evaluate the Probability of Success Journal of Ocular Pharmacology and Therapeutics, 2019
- Ceftolozane/Tazobactam: A New Cephalosporin and β-Lactamase Inhibitor Combination The Annals of Pharmacotherapy, 2015
- Clinical applications of azithromycin microspheres in respiratory tract infections International Journal of Nanomedicine, 2007
- Clinical perspectives on new antimicrobials: focus on fluoroquinolones Clinical Infectious Diseases, 2001
- Together or Apart? Revealing the Impact of Dietary Interventions on Bioavailability of Quinolones: A Systematic Review with Meta-analyses Clinical Pharmacokinetics, 2024
- IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients Breast Cancer Research and Treatment, 2017
- Ceftolozane-tazobactam: A new-generation cephalosporin American Journal of Health-System Pharmacy, 2015
- The Combination of Meropenem and Levofloxacin Is Synergistic with Respect to both Pseudomonas aeruginosa Kill Rate and Resistance Suppression Antimicrobial Agents and Chemotherapy, 2010
- Cancer Drug Repurposing: Pathophysiology, Therapeutic Targeting and Translational Opportunities Transdisciplinary Medical, Clinical and Health Research, 2026
- Pharmacokinetic-Pharmacodynamic Determinants of Clinical Outcomes for Rifampin-Resistant Tuberculosis: A Multisite Prospective Cohort Study Clinical Infectious Diseases, 2022
- Fluoroquinolone Efficacy against Tuberculosis Is Driven by Penetration into Lesions and Activity against Resident Bacterial Populations Antimicrobial Agents and Chemotherapy, 2019
- Plazomicin: a new aminoglycoside in the fight against antimicrobial resistance Therapeutic Advances in Infectious Disease, 2020
- Levofloxacin and warfarin interaction The Annals of Pharmacotherapy, 2002
- Effectiveness of Levofloxacin Eye Drops – A Microbiological Perspective European Ophthalmic Review, 2009
- Levofloxacin-Induced QTc Prolongation Depends on the Time of Drug Administration CPT: Pharmacometrics & Systems Pharmacology, 2016
- Maximizing Pharmacodynamics with High-Dose Levofloxacin Hospital Pharmacy, 2005
- Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial Critical Care, 2019
- Bronchopulmonary pharmacokinetic and pharmacodynamic profiles of levofloxacin 750 mg once daily in adults undergoing treatment for acute exacerbation of chronic bronchitis Pulmonary Pharmacology & Therapeutics, 2012
- Clinical validation of antimicrobial dosing regimens for continuous renal replacement therapy based on an ex vivo dosing algorithm Journal of Antimicrobial Chemotherapy, 2025
- Efficacy of ultra-short course chemotherapy for new smear positive drug susceptible pulmonary tuberculosis: study protocol of a multicenter randomized controlled clinical trial BMC Infectious Diseases, 2017
- Efficacy and safety of levofloxacin in the context of other contemporary fluoroquinolones: a review Current Therapeutic Research, 2003
- Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid Antimicrobial agents and chemotherapy, 1995
- Pharmacokinetics and pharmacodynamics of gatifloxacin against Streptococcus pneumoniae and Staphylococcus aureus in a granulocyte-rich exudate Antimicrobial agents and chemotherapy, 2002
- Drug interactions with clinafloxacin Antimicrobial agents and chemotherapy, 2001
- Evaluation of tigecycline penetration into colon wall tissue and epithelial lining fluid using a population pharmacokinetic model and Monte Carlo simulation Antimicrobial agents and chemotherapy, 2007
- Levofloxacin pharmacokinetics in adult cystic fibrosis Chest, 2007
- Penetration of meropenem into epithelial lining fluid of patients with ventilator-associated pneumonia Antimicrobial agents and chemotherapy, 2011
- Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103) Cancer chemotherapy and pharmacology, 2014
- Dose findings of antofloxacin hydrochloride for treating bacterial infections in an early clinical trial using PK-PD parameters in healthy volunteers Acta pharmacologica Sinica, 2012
- Comparison of the pharmacodynamics of biapenem in bronchial epithelial lining fluid in healthy volunteers given half-hour and three-hour intravenous infusions Antimicrobial agents and chemotherapy, 2009
- Optimal dose finding of garenoxacin based on population pharmacokinetics/pharmacodynamics and Monte Carlo simulation European journal of clinical pharmacology, 2012
- Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases Scientific reports, 2015
- A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma British journal of haematology, 2016
- Oral Candida in Patients with Fixed Orthodontic Appliance: In Vitro Combination Therapy BioMed research international, 2017
- Influence of borderline cefepime MIC on the outcome of cefepime-susceptible Pseudomonas aeruginosa bacteremia treated with a maximal cefepime dose: a hospital-based retrospective study Annals of clinical microbiology and antimicrobials, 2017
- Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous Moxifloxacin in Pediatric Patients: Dose Optimization in a Phase 1 Study Journal of clinical pharmacology, 2019
- Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Fludarabine and Cytarabine, in Pediatric Relapsed or Refractory Acute Leukemia Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016
- Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study BMJ open, 2018
- Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial Trials, 2022
- Population Pharmacokinetic Model and Limited Sampling Strategies for Personalized Dosing of Levofloxacin in Tuberculosis Patients Antimicrobial agents and chemotherapy, 2018
- Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trial Trials, 2022
- Safety and pharmacokinetics-pharmacodynamics of a shorter tuberculosis treatment with high-dose pyrazinamide and rifampicin: a study protocol of a phase II clinical trial (HighShort-RP) BMJ open, 2022
- Pharmacokinetics and pharmacodynamics of oral pradofloxacin administration in dogs American journal of veterinary research, 2018
- Testing novel strategies for patients hospitalised with HIV-associated disseminated tuberculosis (NewStrat-TB): protocol for a randomised controlled trial Trials, 2024
- Application of Visual Gene Clip-Based Tailored Therapy for the Eradication of Helicobacter pylori BioMed research international, 2021
- Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects Antimicrobial agents and chemotherapy, 2003
- Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers Journal of clinical pharmacology, 1996
- Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections Antimicrobial agents and chemotherapy, 2001
- Tigecycline population pharmacokinetics in patients with community- or hospital-acquired pneumonia Antimicrobial agents and chemotherapy, 2010
- Pharmacokinetics-pharmacodynamics of tigecycline in patients with community-acquired pneumonia Antimicrobial agents and chemotherapy, 2012
- Thorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjects British journal of clinical pharmacology, 2014
- Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis Antimicrobial agents and chemotherapy, 2011
- Evaluation of Daptomycin Exposure and Efficacy and Safety Endpoints To Support Risk-versus-Benefit Considerations Antimicrobial agents and chemotherapy, 2015
- Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled trial European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017
- A Randomized Study of the Single-Dose Safety, Pharmacokinetics, and Food Effect of Chinfloxacin and Its Effect on Thorough QT/QTc Interval in Healthy Chinese Volunteers Antimicrobial agents and chemotherapy, 2018
- Pharmacometrics-based dose selection of levofloxacin as a treatment for postexposure inhalational anthrax in children Antimicrobial agents and chemotherapy, 2010
- Population pharmacokinetics and pharmacodynamics of ofloxacin in South African patients with multidrug-resistant tuberculosis Antimicrobial agents and chemotherapy, 2012
- Pharmacokinetics and pharmacodynamics of multiple-dose intravenous nemonoxacin in healthy Chinese volunteers Antimicrobial agents and chemotherapy, 2015
- The Prognostic Impact of Dose-attenuated R-CHOP Therapy for Elderly Patients with Diffuse Large B-cell Lymphoma Internal medicine (Tokyo, Japan), 2018
- Brief Report: Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-γ Antibody, in Patients With Discoid Lupus Erythematosus Arthritis & rheumatology (Hoboken, N.J.), 2017
- Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia The Journal of antimicrobial chemotherapy, 2022
- BWC0977, a broad-spectrum antibacterial clinical candidate to treat multidrug resistant infections Nature communications, 2024
- Comparison the cost-efficacy of furazolidone-based versus clarithromycin-based quadruple therapy in initial treatment of Helicobacter pylori infection in a variable clarithromycin drug-resistant region, a single-center, prospective, randomized, open-label study Medicine, 2019
- Optimized dual therapy for treatment-naive patients of Helicobacter pylori infection: A large-scale prospective, multicenter, open-label, randomized controlled study Helicobacter, 2022
- Aqueous humour concentrations after topical apPlication of combinEd levofloxacin-dexamethasone eye dRops and of its single components: a randoMised, assEssor-blinded, parallel-group study in patients undergoing cataract surgery: the iPERME study European journal of clinical pharmacology, 2020
- Efficacy and Safety of PL-5 (Peceleganan) Spray for Wound Infections: A Phase IIb Randomized Clinical Trial Annals of surgery, 2023
- Keverprazan, a novel potassium-competitive acid blocker: Multiple oral doses safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy subjects Clinical and translational science, 2023
- Pharmacokinetics of levofloxacin in non-lactating goats and evaluation of drug effects on resistance in coliform rectal flora Research in veterinary science, 2020
- Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trial The Lancet. Infectious diseases, 2026
- Towards pharmacokinetic boosting of phenoxymethylpenicillin (penicillin-V) using probenecid for the treatment of bacterial infections Scientific reports, 2024
- Different Doses of Ilaprazole for Dual Therapy Versus Bismuth-Quadruple Therapy for Helicobacter pylori Infection: A Three-Arm, Randomized Clinical Trial Helicobacter, 2025
- Quadruple, sequential, and concomitant first-line therapies for H. pylori eradication: a prospective, randomized study Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2018
- Analysis of efficacy and safety of linezolid-based chemotherapeutic regimens for patients with postoperative multidrug-resistant spinal tuberculosis International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022
- Analysis of the drug therapy of gatifloxacin and levofloxacin in the treatment of acute bacterial conjunctivitis Pakistan journal of pharmaceutical sciences, 2018
- Evaluation of efficacy and safety of Lacticaseibacillus rhamnosus LRa05 in the eradication of Helicobacter pylori: a randomized, double-blind, placebo-controlled trial Frontiers in immunology, 2024
- Efficacy and safety of 8-week regimens for the treatment of rifampicin-susceptible pulmonary tuberculosis (TRUNCATE-TB): a prespecified exploratory analysis of a multi-arm, multi-stage, open-label, randomised controlled trial The Lancet. Infectious diseases, 2025
- Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial JAMA, 2018
